Literature DB >> 1722105

The DNA-dependent and RNA-dependent DNA polymerase activities of the reverse transcriptases of human immunodeficiency viruses types 1 and 2.

M Shaharabany1, A Hizi.   

Abstract

We have constructed a series of plasmids which, when introduced into Escherichia coli, induce the overexpression of soluble wild-type and mutated forms of the reverse transcriptases (RTs) from human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2, respectively). These proteins were analyzed previously for their RNA-dependent DNA polymerase (RDDP) and ribonuclease H (RNase H) activities. In the present study we assayed the different mutant RTs for their DNA-dependent DNA polymerase (DDDP) activity, employing an in situ polyacrylamide gel activity assay. The results indicate that both the RDDP and DDDP catalytic functions of HIV-1 RT mutants are affected similarly by mutations suggesting a high degree of overlap between the catalytic domains involved in both activities. Contrariwise, many of the HIV-2 RT mutants display no correlation between these two DNA polymerase activities, that is, the DDDP activity was not affected by the mutations introduced in the native enzyme in contrast to the RDDP activity. We were thus able to generate mutants of HIV-2 RT that unlike the wild-type RT, are capable of transcribing only DNA and not RNA. The disparity in mutational-catalytic relations between the two HIV-related RTs may reflect a possible difference in the structure and folding properties of the two proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722105     DOI: 10.1089/aid.1991.7.883

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases.

Authors:  S Loya; A Rudi; Y Kashman; A Hizi
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

3.  Mode of inhibition of HIV reverse transcriptase by 2-hexaprenylhydroquinone, a novel general inhibitor of RNA-and DNA-directed DNA polymerases.

Authors:  S Loya; A Rudi; Y Kashman; A Hizi
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

4.  Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization.

Authors:  R Taube; S Loya; O Avidan; M Perach; A Hizi
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

5.  Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases.

Authors:  Shoshana Loya; Amira Rudi; Yoel Kashman; Amnon Hizi
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

6.  Resistance to nucleoside analogs of selective mutants of human immunodeficiency virus type 2 reverse transcriptase.

Authors:  M Perach; T Rubinek; A Hizi
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.